Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2666 Views
-
Last post by NHE
-
- 0 Replies
- 1286 Views
-
Last post by frodo
-
- 0 Replies
- 1260 Views
-
Last post by NHE
-
- 0 Replies
- 1360 Views
-
Last post by frodo
-
- 0 Replies
- 1502 Views
-
Last post by NHE
-
- 0 Replies
- 1234 Views
-
Last post by frodo
-
- 0 Replies
- 1585 Views
-
Last post by NHE
-
- 0 Replies
- 1948 Views
-
Last post by DIM
-
- 0 Replies
- 1483 Views
-
Last post by NHE